Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K, Bowen T, Balle Boysen H, Farkas H, Grumach AS, Hide M, Katelaris C, Lockey R, Longhurst H, Lumry WR, Martinez-Saguer I, Moldovan D, Nast A, Pawankar R, Potter P, Riedl M, Ritchie B, Rosenwasser L, Sánchez-Borges M, Zhi Y, Zuraw B, Craig T (2018) The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy 73:1575–1596. https://doi.org/10.1111/all.13384

Article  CAS  PubMed  Google Scholar 

Weis M (2009) Clinical review of hereditary angioedema: diagnosis and management. Postgrad Med 121:113–120. https://doi.org/10.3810/pgm.2009.11.2071

Article  PubMed  Google Scholar 

Lumry WR (2013) Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema. Am J Manag Care 19:s103–s110

PubMed  Google Scholar 

Zotter Z, Csuka D, Szabó E, Czaller I, Nébenführer Z, Temesszentandrási G, Fust G, Varga L, Farkas H (2014) The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. Orphanet J Rare Dis 9:44. https://doi.org/10.1186/1750-1172-9-44

Article  PubMed  PubMed Central  Google Scholar 

Walker K, Perkins M, Dray A (1995) Kinins and kinin receptors in the nervous system. Neurochem Int 26:1–16. https://doi.org/10.1016/0197-0186(94)00114-a. (discussion 17–26)

Article  CAS  PubMed  Google Scholar 

Choi SI, Hwang SW (2018) Depolarizing effectors of bradykinin signaling in nociceptor excitation in pain perception. Biomol Ther (Seoul) 26:255–267. https://doi.org/10.4062/biomolther.2017.127

Article  CAS  PubMed  Google Scholar 

Dubois EA, Cohen AF (2010) Icatibant. Br J Clin Pharmacol 69:425–426. https://doi.org/10.1111/j.1365-2125.2010.03642.x

Article  PubMed  PubMed Central  Google Scholar 

Lumry WR, Farkas H, Moldovan D, Toubi E, Baptista J, Craig T, Riedl M (2015) Icatibant for multiple hereditary angioedema attacks across the controlled and open-label extension phases of FAST-3. Int Arch Allergy Immunol 168:44–55. https://doi.org/10.1159/000441060

Article  PubMed  Google Scholar 

Takeda (2021) Cinryze® prescribing information. http://pi.shirecontent.com/PI/PDFs/Cinryze_USA_ENG.pdf. Accessed 11 October 2021

CSL Behring (2022) Haegarda® prescribing information. https://labeling.cslbehring.com/PI/US/HAEGARDA/EN/HAEGARDA-Prescribing-Information.pdf. Accessed 18 August 2023

Biocryst Pharmaceuticals, Inc. (2020) ORLADEYO™ (berotralstat) capsules, for oral use, prescribing information. https://www.biocryst.com/wp-content/uploads/2020/12/ORLADEYO_PI_V1_2020.pdf. Accessed 18 August 2023

Shire plc (2018) TAKHZYRO® prescribing information. https://www.shirecontent.com/PI/PDFs/TAKHZYRO_USA_ENG.pdf. Accessed 11 October 2021

Aghamiri SS, Amin R, Helikar T (2021) Recent applications of quantitative systems pharmacology and machine learning models across diseases. J Pharmacokinet Pharmacodyn 49:1–19. https://doi.org/10.1007/s10928-021-09790-9

Article  CAS  Google Scholar 

Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. The Lancet 351:1693–1697. https://doi.org/10.1016/S0140-6736(97)09137-X

Article  CAS  Google Scholar 

Wang Y, Marier J-F, Kassir N, Chang C, Martin P (2020) Pharmacokinetics, pharmacodynamics, and exposure-response of lanadelumab for hereditary angioedema. Clin Transl Sci 13:1208–1216. https://doi.org/10.1111/cts.12806

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Jomphe C, Marier JF, Martin P (2021) Population pharmacokinetics and exposure-response analyses to guide dosing of icatibant in pediatric patients with hereditary angioedema. J Clin Pharmacol 61:555–564. https://doi.org/10.1002/jcph.1768

Article  CAS  PubMed  Google Scholar 

Shire (2017) Cinryze(R) assessment report. https://www.ema.europa.eu/en/documents/assessment-report/cinryze-epar-public-assessment-report_en.pdf. Accessed October 11, 2021

Chyung Y, Vince B, Iarrobino R, Sexton D, Kenniston J, Faucette R, TenHoor C, Stolz LE, Stevens C, Biedenkapp J (2014) A phase 1 study investigating DX-2930 in healthy subjects. Ann Allergy Asthma Immunol 113:460-466.e462

Article  CAS  PubMed  Google Scholar 

Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R (2017) Inhibiting plasma kallikrein for hereditary angioedema prophylaxis. N Engl J Med 376:717–728. https://doi.org/10.1056/NEJMoa1605767

Article  CAS  PubMed  Google Scholar 

Kaufman N, Page JD, Pixley RA, Schein R, Schmaier AH, Colman RW (1991) Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 77:2660–2667

Article  CAS  PubMed  Google Scholar 

Shah DK, Betts AM (2012) Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn 39:67–86

Article  CAS  PubMed  Google Scholar 

Navidi WC (2008) Statistics for engineers and scientists, 2nd end. McGraw-Hill Higher Education, New York, NY, p 901.  https://books.google.com/books/about/Statistics_for_Engineers_and_Scientists.html?id=I9FFAQAAIAAJ

Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT (2010) The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407–414

Article  PubMed  Google Scholar 

Bork K, Staubach P, Eckardt AJ, Hardt J (2006) Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101:619–627. https://doi.org/10.1111/j.1572-0241.2006.00492.x

Article  CAS  PubMed  Google Scholar 

Gompels M, Lock R, Abinun M, Bethune C, Davies G, Grattan C, Fay A, Longhurst H, Morrison L, Price A (2005) C1 inhibitor deficiency: consensus document. Clin Exp Immunol 139:379–394. https://doi.org/10.1111/j.1365-2249.2005.02726.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bork K, Hardt J, Schicketanz K-H, Ressel N (2003) Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 163:1229–1235. https://doi.org/10.1001/archinte.163.10.1229

Article  PubMed  Google Scholar 

Bygum A, Busse P, Caballero T, Maurer M (2017) Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema. Front Med (Lausanne) 4:212. https://doi.org/10.3389/fmed.2017.00212

Article  PubMed  Google Scholar 

Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I (2018) Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial. JAMA 320:2108–2121. https://doi.org/10.1001/jama.2018.16773

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, Craig T, Grant JA, Hurewitz D, Bielory L (2010) Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363:513–522. https://doi.org/10.1056/NEJMoa0805538

Article  CAS  PubMed  Google Scholar 

Brenan KE, Campbell SL, Petzold LR (1995) Numerical Solution of Initial-Value Problems in Differential-Algebraic Equations. Soc Industrial Appl Math [SIAM], https://doi.org/10.1137/1.9781611971224

Feehery WH, Tolsma JE, Barton PI (1997) Efficient sensitivity analysis of large-scale differential-algebraic systems. Appl Numer Math 25:41–54

Article  Google Scholar 

Goh CJ, Teo KL (1988) Control parametrization: A unified approach to optimal control problems with general constraints. Automatica 24:3–18

Article  Google Scholar 

Zhu C, Byrd RH, Lu P, Nocedal J (1997) Algorithm 778: L-BFGS-B: Fortran subroutines for large-scale bound-constrained optimization. ACM Trans Math Software 23:550–560

Article  Google Scholar 

Nussberger J, Cugno M, Cicardi M (2002) Bradykinin-mediated angioedema. N Engl J Med 347:621–622. https://doi.org/10.1056/NEJM200208223470820

Article  PubMed  Google Scholar 

Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M (2014) High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C 1-inhibitor deficiency. Clin Exp Allergy 44:1503–1514. https://doi.org/10.1111/cea.12293